JEM: T-cells' mechanism for fighting Zika virus infection
Last Update: 2020-06-17
Search more information of high quality chemicals, good prices and reliable suppliers, visit
, June 8, 2020 /PRNewswire/ -- Biogu BIOON/--- Japanese encephalitis virus is a very common mosquito-borne virus, with more than 68,000 people suffering from encephalitis each year, and a quarter of these patients dieThe mosquito-borne virus is most common in Southeast Asia and causes severe neurological damage and mental illnessthere are currently no drugs to cure Japanese encephalitis, but there is a vaccine against the Japanese encephalitis virus (JEV)in a new study published on June 5, 2020 in Journal of Experimental Medicine, scientists from the(picture:scientists from LJI showed that antibodies against JEV are "cross-reactive" and can recognize the Zika virusThe bad news is that these antibodies actually increase the risk of Zika virus infectionIn addition, studies have shown that T-cells can help mitigate this riskIn the new study,, Shresta and her colleagues extracted antibodies from mice infected with JEV or jev-inoculated volunteers and injected them into healthy miceHealthy mice were then infected with the Zika virus, and the results showed that the mice developed a more severe antibody-enhanced response that led to increased infection of cells and replicationnext, Shresta and her colleagues focused on CD8 plus T cells in mice infected with JEVThey found that CD8 plus T cells that targeted JEV could counteract the harmful effects of cross-reactive antibodies"These JEV-induced T cells do recognize and get rid of Zika virus infection," Shresta said"
in short, CD8 plus T cells can improve survival and reduce viral load in miceFuture JEV vaccine designs will require similar reactions from CD8 plus T cells to help people avoid antibody-enhancing reactions that occur after Zika virus infection (Bio Valley Bioon.com) source: T cells can counteract red matter of the disease-borne-viruses
original origin: Chen, D., et al (2020) the encephalitis virus-primed CD8 s T cells
Journal of The doi.org/10.1084/jem.20192152.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to email@example.com
. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.